Hypertension treatment by Rhodan-Calcium-Diuretin

CONTEXT: The cost-effectiveness of the treatment of hypertension has scarcely been investigated in population-based studies. Most data come from secondary analysis of clinical trials and administrative sources. OBJECTIVE: To describe the healthcare costs for outpatient hypertension treatment in comparison with diabetes mellitus and chronic bronchitis, and to examine the cost-effectiveness of different classes of antihypertensive drugs. DESIGN: Cross-sectional population-based study. SETTING: Urban area of Pelotas, southern Brazil. PARTICIPANTS: Individuals aged 20-69 years, identified through multi-stage probability sampling. METHODS: Participants were interviewed at home. Demographic data, education, income, smoking, previous morbidity, use of medicine and other characteristics were assessed via a pre-tested questionnaire, and blood pressure while seated was measured in a standardized way. RESULTS: Approximately 24% of the participants had high blood pressure or were taking antihypertensive drugs, and among these, 33% had had a physician consultation during the month preceding the interview. The monthly mean costs of care for hypertension (R$ 89.90), diabetes (R$ 80.64) and bronchitis (R$ 92.63) were similar. Treatment of hypertension consumed 22.9% of the per-capita income, corresponding to R$ 392.76 spent per year exclusively on antihypertensive drugs. Most of the direct costs associated with hypertension and diabetes were spent on drugs, while patients with bronchitis had greater expenditure on appointments. The cost-effectiveness relationship was more favorable for diuretics (116.3) and beta blockers (228.5) than for ACE inhibitors (608.5) or calcium channel blockers (762.0). CONCLUSION: The costs of hypertension care are mainly dependent on the expenditure on blood pressure-lowering drugs. Treatment of hypertension with diuretics or beta blockers was more cost-effective than treatment with ACE inhibitors and calcium channel blockers.

Download Full-text

HYPERTENSION THERAPY USING ACUPUNCTURE AND HERBALS OF LEDS AND CARROTS

Journal Of Vocational Health Studies ◽

10.20473/jvhs.v2.i2.2018.67-73 ◽

2019 ◽

Vol 2 (2) ◽

pp. 67

Author(s):

Ulfa Nur Khasanah ◽

Ario Imandiri ◽

Myrna Adianti

Keyword(s):

Blood Pressure ◽

Acupuncture Therapy ◽

Daucus Carota ◽

Hypotensive Effect ◽

Reduce Blood Pressure ◽

Apium Graveolens ◽

Hypertension Treatment ◽

Daucus Carota L ◽

Treatment Of Hypertension ◽

Hypertension Therapy

Background: Hypertension or high blood pressure is an increase in systolic blood pressure of more than 140 mmHg and diastolic blood pressure of more than 90 mmHg in two measurements with an interval of five minutes in rest or quiet state. Hypertension in Traditional Chinese Medicine (TCM) is categorized in Xuan Yuan (vertigo) and Tou Tong (headache). Purpose: To determine the effect of acupuncture therapy using Fengchi (GB20), Taichong (LR3), Hegu (LI4) points and 2 additional points, namely Xuehai (SP10) and Chize (LU5) and herbs therapy for celery (Apium graveolens L.) and carrots (Daucus carota L.) for people with hypertension. Methods: Treatment of hypertension with acupuncture and herbs therapy. Acupuncture therapy was carried out at Fengchi (GB20), Taichong (LR3), Hegu (LI4) points with the principle of liver fire sedation and Xuehai (SP10) and Chize (LU5) with the tonification principle. In herbs therapy, patients were given fresh celery (Apium graveolens L.) and carrots (Daucus carota L.) which had a hypotensive effect. Results: Hypertension treatment with acupuncture therapy was given 12 times, 3 times a week. Herbs therapy was given for 4 weeks, taken once a day in the afternoon with a dose of 200 ml. This therapy could reduce the patient's blood pressure. Conclusion: Acupuncture therapy in Fengchi (GB20), Taichong (LR3), Hegu (LI4) Xuehai (SP10), Chize (LU5) plus fresh celery herbs (Apium graveolens L.) and carrots (Daucus carota L.) could reduce blood pressure and additional complaints in hypertensive patients

Download Full-text

PENGARUH TERAPI TERTAWA TERHADAP PENURUNAN TEKANAN DARAH LANSIA DI UPT PANTI WREDHA BUDHI DHARMA YOGYAKARTA

Surya Medika: Jurnal Ilmiah Ilmu Keperawatan dan Ilmu Kesehatan Masyarakat ◽

10.32504/sm.v13i1.99 ◽

2019 ◽

Vol 13 (1) ◽

Author(s):

Niken Setyaningrum ◽

Andri Setyorini ◽

Fachruddin Tri Fitrianta

Keyword(s):

Blood Pressure ◽

Data Analysis ◽

The Elderly ◽

Control Group ◽

Group Comparison ◽

Control Blood Pressure ◽

Men And Women ◽

Treatment Of Hypertension ◽

Before And After ◽

The Difference

ABSTRACTBackground: Hypertension is one of the most common diseases, because this disease is suffered byboth men and women, as well as adults and young people. Treatment of hypertension does not onlyrely on medications from the doctor or regulate diet alone, but it is also important to make our bodyalways relaxed. Laughter can help to control blood pressure by reducing endocrine stress andcreating a relaxed condition to deal with relaxation.Objective: The general objective of the study was to determine the effect of laughter therapy ondecreasing elderly blood pressure in UPT Panti Wredha Budhi Dharma Yogyakarta.Methods: The design used in this study is a pre-experimental design study with one group pre-posttestresearch design where there is no control group (comparison). The population in this study wereelderly aged over> 60 years at 55 UPT Panti Wredha Budhi Dharma Yogyakarta. The method oftaking in this study uses total sampling. The sample in this study were 55 elderly. Data analysis wasused to determine the difference in blood pressure before and after laughing therapy with a ratio datascale that was using Pairs T-TestResult: There is an effect of laughing therapy on blood pressure in the elderly at UPT Panti WredhaBudhi Dharma Yogyakarta marked with a significant value of 0.000 (P <0.05)

Download Full-text

Device therapy of resistant hypertension

Orvosi Hetilap ◽

10.1556/oh.2013.29543 ◽

2013 ◽

Vol 154 (6) ◽

pp. 203-208 ◽

Cited By ~ 1

Author(s):

Gábor Simonyi ◽

J. Róbert Bedros ◽

Mihály Medvegy

Keyword(s):

Blood Pressure ◽

Cardiovascular Risk ◽

Resistant Hypertension ◽

Carotid Sinus ◽

Maximum Tolerated Dose ◽

Reduce Blood Pressure ◽

Nerve Fibers ◽

Uncontrolled Hypertension ◽

Sympathetic Nerve Fibers ◽

Treatment Of Hypertension

It is well known that hypertension is an independent cardiovascular risk factor. Treatment of hypertension frequently includes administration of three or more drugs. Resistant hypertension is defined when blood pressure remains above target value despite full doses (the patient’s maximum tolerated dose) of antihypertensive medication consisting of at least three different classes of drugs including a diuretic. Pharmacological treatment of hypertension is often unsuccessful despite the increasing number of drug combinations. Uncontrolled hypertension, however, increases the cardiovascular risk. Device treatment of resistant hypertension is currently testing two major fields. One of them the stimulation of baroreceptors in the carotid sinus and the other is radiofrequency ablation of sympathetic nerve fibers around renal arteries to reduce blood pressure in drug resistant hypertension. Orv. Hetil., 2013, 154, 203–208.

Download Full-text

Blood pressure response to out-patient drug treatment of hypertension in 1973 – 1993 at Korle-Bu Teaching Hospital, Accra, Ghana

West African Journal of Medicine ◽

10.4314/wajm.v22i2.27945 ◽

2004 ◽

Vol 22 (2) ◽

Author(s):

IF Adukwei Hesse

Keyword(s):

Blood Pressure ◽

Drug Treatment ◽

Teaching Hospital ◽

Blood Pressure Response ◽

Pressure Response ◽

Treatment Of Hypertension

Download Full-text

IS DETERMINATION OF THE RETINAL BLOOD PRESSURE OF VALUE IN MODERN TREATMENT OF HYPERTENSION?

Acta Ophthalmologica ◽

10.1111/j.1755-3768.1958.tb00832.x ◽

2009 ◽

Vol 36 (3) ◽

pp. 536-539

Author(s):

S. Björk-von Bahr

Keyword(s):

Blood Pressure ◽

Treatment Of Hypertension ◽

Modern Treatment

Download Full-text

Causes of Resistant Hypertension Detected by a Standardized Algorithm

International Journal of Hypertension ◽

10.1155/2012/392657 ◽

2012 ◽

Vol 2012 ◽

pp. 1-5 ◽

Cited By ~ 2

Author(s):

Livia Beatriz Santos Limonta ◽

Letícia dos Santos Valandro ◽

Flávio Gobis Shiraishi ◽

Pasqual Barretti ◽

Roberto Jorge da Silva Franco ◽

...

Keyword(s):

Blood Pressure ◽

Resistant Hypertension ◽

Secondary Hypertension ◽

Control Blood Pressure ◽

Primary Level ◽

Standardized Protocol ◽

Frequent Use ◽

Drug Classes ◽

Treatment Of Hypertension ◽

Secondary Causes

Resistant hypertension (RH) is characterized by blood pressure above 140 × 90 mm Hg, despite the use, in appropriate doses, of three antihypertensive drug classes, including a diuretic, or the need of four classes to control blood pressure. Resistant hypertension patients are under a greater risk of presenting secondary causes of hypertension and may be benefited by therapeutical approach for this diagnosis. However, the RH is currently little studied, and more knowledge of this clinical condition is necessary. In addition, few studies had evaluated this issue in emergent countries. Therefore, we proposed the analysis of specific causes of RH by using a standardized protocol in Brazilian patients diagnosed in a center for the evaluation and treatment of hypertension. The management of these patients was conducted with the application of a preformulated protocol which aimed at the identification of the causes of resistant hypertension in each patient through management standardization. The data obtained suggest that among patients with resistant hypertension there is a higher prevalence of secondary hypertension, than that observed in general hypertensive ones and a higher prevalence of sleep apnea as well. But there are a predominance of obesity, noncompliance with diet, and frequent use of hypertensive drugs. These latter factors are likely approachable at primary level health care, since that detailed anamneses directed to the causes of resistant hypertension are applied.

Download Full-text